Welcome to Skilled in the Art. I'm Law.com IP reporter Scott Graham.

Questions, questions, questions—we've got a truckload following the Supreme Court's Arthrex decision. Only the USPTO and Federal Circuit can answer them, but some savvy lawyers are venturing their best guesses below. Also, a Fenwick & West team has now defensed two patent infringement trials for Amazon.com in Texas in the last nine months. Incoming Chief Judge Kimberly Moore and outgoing Chief Judge Sharon Prost headlined a dazzling week of programming at the Federal Circuit Bench & Bar Conference. And a group of inventors is poised to ask Chief U.S. District Judge Rodney Gilstrap to put PTAB proceedings on ice.

As always, you can email me your feedback and follow me on Twitter.

Drew Hirshfeld, performing the functions and duties of the Under Secretary of Commerce for Intellectual Property and Director of the USPTO. (Photo: Jay Premack, USPTO)

What Hath Arthrex Wrought?

It seemed as if the Supreme Court was trying to create as little disruption as possible when it chose the remedy for the Appointments Clause violation it found Monday in U.S. v. Arthrex.